Archives: Agenda

INDUSTRY CASE STUDY: How to make planning a successful role through people, processes and performance?

Planning is one the most critical roles in the cynical supply chain. Planners decide how much study drugs produce, source package and distribute and when to do so. Consequently, all the clinical supply chain’s performance indicators (waste, costs, inventories, shortage risks, CO2 emissions, etc) are intimately linked to their actions. While systems help, they are not the main driver of a planning organization’s success.

  • The 4 “P” (People, Process, Product, Performance) for a successful organisation 
  • How to structure a team, including roles and responsibilities to make planning a strategic role 
  • What are the essential processes to enable a high-performing CTS planning 
  • How to make performance a priority and improve it through planning 
  • Illustration through business cases, benchmarks and good practices 

 

TECH SPOTLIGHT: Clinical Trial delay: The data privacy pitfalls that can stall you at submission, site and sale

For sponsors and biotechs, momentum is everything but data privacy gaps have a way of surfacing at the worst possible moment in extremely costly ways. This session walks through three checkpoints where privacy oversights can bring progress to a halt: regulatory submission, site-level execution, and the eventual sale or licensing of trial IP.

  • Submission: the privacy documentation and registration gaps that can delay or derail regulatory filings
  • Site: where data protection responsibilities between sponsor, CRO and site most often break down
  • Sale: why buyers and licensing partners are scrutinising data provenance and privacy compliance more closely, and how gaps can devalue or derail a deal